NIT
BMY icon

NumerixS Investment Technologies’s Bristol-Myers Squibb BMY Stock Holding History

NumerixS Investment Technologies’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-200
Closed -$9K – 1019
2019
Q2 		$9K Sell
200
-83,694
-100% -$3.9M ﹤0.01% 976
2019
Q1 		$4.01M Buy
83,894
+68,145
+433% +$3.39M 0.54% 26
2018
Q4 		$802K Sell
15,749
-4,551
-22% -$245K 0.26% 74
2018
Q3 		$1.26M Buy
+20,300
New +$1.2M 0.24% 106
2018
Q2 		– Sell
-6,638
Closed -$415K – 1138
2018
Q1 		$415K Buy
+6,638
New +$427K 0.1% 218
2017
Q2 		– Sell
-89,874
Closed -$4.89M – 1140
2017
Q1 		$4.89M Buy
89,874
+5,071
+6% +$278K 0.56% 23
2016
Q4 		$4.96M Sell
84,803
-5,917
-7% -$323K 0.63% 21
2016
Q3 		$4.89M Buy
+90,720
New +$5.83M 0.63% 24
2015
Q2 		– Sell
-48,002
Closed -$3.1M – 632
2015
Q1 		$3.1M Buy
+48,002
New +$3.01M 0.56% 32

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NumerixS Investment Technologies's BMY Position: Q3 2019 in Review

NumerixS Investment Technologies sold out of Bristol-Myers Squibb (BMY) in Q3 2019, closing a stake of 200 shares — an estimated $9K sold.

NumerixS Investment Technologies first reported a position in BMY in Q1 2015 and held it in 9 quarters. The position peaked at $4.96M in Q4 2016. 1,814 funds tracked by Wall St. Rank hold BMY as of Q3 2019.

  • NumerixS Investment Technologies reported no remaining Bristol-Myers Squibb position as of Q3 2019 after selling out during the quarter.
  • NumerixS Investment Technologies sold 200 Bristol-Myers Squibb shares in Q3 2019, an estimated $9K.
  • NumerixS Investment Technologies first reported a position in Bristol-Myers Squibb in Q1 2015 and held it in 9 quarters.
  • NumerixS Investment Technologies's Bristol-Myers Squibb position peaked at $4.96M in Q4 2016.
  • 1,814 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2019.

Based on NumerixS Investment Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.